View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
EPA/WATER | RIN: 2040-AA13 | Publication ID: Fall 1997 |
Title: Effluent Guidelines and Standards for the Pharmaceutical Manufacturing Category | |
Abstract: EPA is developing revised effluent limitation guidelines and standards for the pharmaceutical manufacturing industry, including limitations on toxic and non-conventional volatile organic pollutants. EPA intends to promulgate this rule concurrently with air emission standards. See separate entry for "NESHAP: Pharmaceuticals Production" (RIN 2060-AE83). | |
Agency: Environmental Protection Agency(EPA) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 40 CFR 439 | |
Legal Authority: 33 USC 1311 Clean Water Act sec 301 33 USC 1314 Clean Water Act sec 304 33 USC 1316 Clean Water Act sec 306 33 USC 1317 Clean Water Act sec 307 33 USC 1361 Clean Water Act sec 501 |
Legal Deadline:
|
||||||||||||
Timetable:
|
Additional Information: SAN No. 1427. ^PRFA: N | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal, Local, State |
Included in the Regulatory Plan: No | |
Agency Contact: Frank Hund Environmental Protection Agency Water 4303, Washington, DC 20460 Phone:202 260-7182 Fax:202 260-7185 Email: hund.frank@epa.gov |